Kim Moran‐Jones

4.7k total citations
16 papers, 562 citations indexed

About

Kim Moran‐Jones is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Kim Moran‐Jones has authored 16 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Cell Biology. Recurrent topics in Kim Moran‐Jones's work include RNA Research and Splicing (7 papers), Cell Adhesion Molecules Research (3 papers) and RNA and protein synthesis mechanisms (3 papers). Kim Moran‐Jones is often cited by papers focused on RNA Research and Splicing (7 papers), Cell Adhesion Molecules Research (3 papers) and RNA and protein synthesis mechanisms (3 papers). Kim Moran‐Jones collaborates with scholars based in Australia, United Kingdom and United States. Kim Moran‐Jones's co-authors include Ross Smith, Keith S. Hoek, Trent P. Munro, Jianguo Shan, Jim C. Norman, Marc D. Jones, Joan Grindlay, Mark J. Snee, Grahame J. Kidd and Goli Samimi and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Kim Moran‐Jones

16 papers receiving 557 citations

Peers

Countries citing papers authored by Kim Moran‐Jones

Since Specialization

Citations

This map shows the geographic impact of Kim Moran‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Moran‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Moran‐Jones more than expected).

Fields of papers citing papers by Kim Moran‐Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Moran‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Moran‐Jones. The network helps show where Kim Moran‐Jones may publish in the future.

Co-authorship network of co-authors of Kim Moran‐Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Moran‐Jones. A scholar is included among the top collaborators of Kim Moran‐Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Moran‐Jones. Kim Moran‐Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL 2022 ·Cancer Research ·Russell Moser, James Annis, Olga Nikolova, (unknown), Kay E. Gurley, Eduardo Méndez, Kim Moran‐Jones, Craig Dorrell, Rosalie C. Sears, Calvin J. Kuo, Haiyong Han, Andrew V. Biankin, Carla Grandori, Daniel D. Von Hoff, Christopher J. Kemp	4
2	The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer 2016 ·Molecular Diagnosis & Therapy ·Kim Moran‐Jones	10
3	INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models 2015 ·Scientific Reports ·Kim Moran‐Jones, (unknown), Goli Samimi	18
4	Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer 2015 ·Oncotarget ·Kim Moran‐Jones, Brian Gloss, Rajmohan Murali, David K. Chang, Emily K. Colvin, Marc D. Jones, Samuel Yuen, Viive M. Howell, (unknown), Carol Wong, Suzanne Spong, Christopher J. Scarlett, Neville F. Hacker, Sue Ghosh, Samuel C. Mok, Michael J. Birrer, Goli Samimi	36
5	ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer 2014 ·Molecular Cancer ·Brian Gloss, Kim Moran‐Jones, (unknown), María J. González, James Scurry, Neville F. Hacker, Robert L. Sutherland, Susan J. Clark, Goli Samimi	34
6	β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model 2012 ·Scientific Reports ·Kim Moran‐Jones, (unknown), Matthew J. Naylor	16
7	c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway 2011 ·Cancer Research ·Jens Rauch, Kim Moran‐Jones, Valérie Albrecht, Thomas Schwarzl, Keith D. Hunter, Olivier Gires, Walter Kölch	51
8	FAK Deletion Promotes p53-Mediated Induction of p21, DNA-Damage Responses and Radio-Resistance in Advanced Squamous Cancer Cells 2011 ·PLoS ONE ·Kathryn Graham, Kim Moran‐Jones, Owen J. Sansom, Valerie G. Brunton, Margaret C. Frame	26
9	hnRNP A2 Regulates Alternative mRNA Splicing of TP53INP2 to Control Invasive Cell Migration 2009 ·Cancer Research ·Kim Moran‐Jones, Joan Grindlay, Marc D. Jones, Ross Smith, Jim C. Norman	68
10	VEGFR1 (Flt1) Regulates Rab4 Recycling to Control Fibronectin Polymerization and Endothelial Vessel Branching 2009 ·Traffic ·Matt Jones, Patrick T. Caswell, Kim Moran‐Jones, (unknown), Simon T. Barry, Alexandra Gampel, (unknown), Jim C. Norman	36
11	Molecular Recognition of an RNA Trafficking Element by Heterogeneous Nuclear Ribonucleoprotein A2 2006 ·Biochemistry ·Michael J. Landsberg, Kim Moran‐Jones, Ross Smith	14
12	?IV tubulin is selectively expressed by oligodendrocytes in the central nervous system 2005 ·Glia ·Nobuo Terada, Grahame J. Kidd, Michael Kinter, Carl Bjartmar, Kim Moran‐Jones, Bruce D. Trapp	28
13	hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere 2005 ·Nucleic Acids Research ·Kim Moran‐Jones	72
14	Heterogeneous Nuclear Ribonucleoprotein A3, a Novel RNA Trafficking Response Element-binding Protein 2002 ·Journal of Biological Chemistry ·(unknown), Kim Moran‐Jones, Jianguo Shan, Trent P. Munro, Mark J. Snee, Keith S. Hoek, Ross Smith	98
15	hnRNP A3, A novel RNA cytoplasmic trafficking response element binding protein 2001 ·(unknown), Mark J. Snee, Kim Moran‐Jones, Trent P. Munro, Grahame J. Kidd, Richard Smith	1
16	Binding of an RNA Trafficking Response Element to Heterogeneous Nuclear Ribonucleoproteins A1 and A2 2000 ·Journal of Biological Chemistry ·Jianguo Shan, Kim Moran‐Jones, Trent P. Munro, Grahame J. Kidd, Donald J. Winzor, Keith S. Hoek, Ross Smith	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact